Management of type 2 diabetes in patients with frailty.
作者信息
Hawker Kara, Akter Ripa, Molnar Frank, Frank Chris
机构信息
Internal medicine resident in the Department of Medicine at the University of Ottawa in Ontario.
Residency Training Program Director in the Division of Geriatric Medicine in the Department of Medicine at the University of Ottawa and Clinician Investigator at the Ottawa Hospital Research Institute.
出版信息
Can Fam Physician. 2024 Jan;70(1):30-32. doi: 10.46747/cfp.700130.
Abstract
摘要
相似文献
1
Management of type 2 diabetes in patients with frailty.
Can Fam Physician. 2024 Jan;70(1):30-32. doi: 10.46747/cfp.700130.
2
Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia.
Int J Environ Res Public Health. 2022 Jul 16;19(14):8677. doi: 10.3390/ijerph19148677.
3
Low glycated hemoglobin level is associated with severity of frailty in Japanese elderly diabetes patients.
J Diabetes Investig. 2018 Mar;9(2):419-425. doi: 10.1111/jdi.12698. Epub 2017 Jul 23.
4
Influencing factors of oral frailty in elderly patients with type 2 diabetes in China: a cross-sectional study based on the integral model of frailty.
BMC Oral Health. 2025 Apr 11;25(1):546. doi: 10.1186/s12903-025-05815-8.
5
Frailty Syndrome and sarcopenia in older adults with and without type 2 diabetes mellitus in the municipality of Sinop, Mato Grosso: an epidemiological study.
Rev Lat Am Enfermagem. 2023 Dec 4;31:e4076. doi: 10.1590/1518-8345.6677.4076. eCollection 2023.
6
Both pre-frailty and frailty increase healthcare utilization and adverse health outcomes in patients with type 2 diabetes mellitus.
Cardiovasc Diabetol. 2018 Sep 27;17(1):130. doi: 10.1186/s12933-018-0772-2.
7
Assessment of frailty in the person with type 2 diabetes mellitus: Expert analysis.
Rev Clin Esp (Barc). 2023 Nov;223(9):552-561. doi: 10.1016/j.rceng.2023.09.008. Epub 2023 Sep 16.
8
Frailty in elderly diabetes patients.
Endocr J. 2018 Jan 30;65(1):1-11. doi: 10.1507/endocrj.EJ17-0390. Epub 2017 Dec 14.
9
Multimorbidity and frailty in middle-aged adults with type 2 diabetes mellitus.
Ann Fam Med. 2022 Apr 1;20(20 Suppl 1):2910. doi: 10.1370/afm.20.s1.2910.
10
The influence of frailty syndrome on quality of life in elderly patients with type 2 diabetes.
Qual Life Res. 2021 Sep;30(9):2487-2495. doi: 10.1007/s11136-021-02829-x. Epub 2021 Apr 8.
引用本文的文献
1
Family medicine is complexity medicine.
Can Fam Physician. 2024 Jan;70(1):7. doi: 10.46747/cfp.70017.
本文引用的文献
1
Diuretics, SGLT2 inhibitors and falls in older heart failure patients: to prescribe or to deprescribe? A clinical review.
Eur Geriatr Med. 2023 Aug;14(4):659-674. doi: 10.1007/s41999-023-00752-7. Epub 2023 Feb 3.
2
The role of sodium-glucose co-transporter-2 inhibitors in frail older adults with or without type 2 diabetes mellitus.
Age Ageing. 2022 Oct 6;51(10). doi: 10.1093/ageing/afac201.
3
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation. 2022 Oct 18;146(16):1210-1224. doi: 10.1161/CIRCULATIONAHA.122.061754. Epub 2022 Aug 27.
4
The Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists on Cardiorenal Outcomes: Systematic Review and Meta-analysis.
Can J Cardiol. 2022 Aug;38(8):1201-1210. doi: 10.1016/j.cjca.2022.05.011.
5
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults.
Can J Cardiol. 2022 Aug;38(8):1153-1167. doi: 10.1016/j.cjca.2022.04.029.
6
Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies.
Metabolites. 2022 Feb 15;12(2):183. doi: 10.3390/metabo12020183.
7
Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond.
Heart Fail Rev. 2023 May;28(3):667-681. doi: 10.1007/s10741-021-10182-x. Epub 2021 Dec 2.
8
Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes.
Diabetes Metab. 2021 Nov;47(6):101275. doi: 10.1016/j.diabet.2021.101275. Epub 2021 Sep 2.
9
Analysis of the Clinical Characteristics of Dipeptidyl Peptidase-4 Inhibitor-Induced Bullous Pemphigoid.
Ann Pharmacother. 2022 Feb;56(2):205-212. doi: 10.1177/10600280211022722. Epub 2021 Jun 9.
10
Careful use to minimize adverse events of oral antidiabetic medications in the elderly.
Expert Opin Pharmacother. 2021 Nov;22(16):2149-2165. doi: 10.1080/14656566.2021.1912735. Epub 2021 Apr 13.
Zotero 插件